This Article is From Apr 12, 2020

Nepal, Bangladesh Among 13 Nations To Get Anti-Malarial Drug From India

They said that the US had asked for 48 lakh tablets of HCQ and India has sanctioned 35.82 lakh tablets, sources said.

Nepal, Bangladesh Among 13 Nations To Get Anti-Malarial Drug From India

India has cleared the first list of 13 countries for hydroxychloroquine.

New Delhi:

India has cleared the first list of 13 countries for hydroxychloroquine (HCQ) which includes US, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Sri Lanka, Afghanistan, Maldives and Bangladesh, the sources said.

They said that the US had asked for 48 lakh tablets of HCQ and India has sanctioned 35.82 lakh tablets, sources said.

Hydroxychloroquine is an anti-malarial drug deemed to be useful in dealing with COVID-19.

The sources said that India has also sent nine MT of Active Pharmaceutical Ingredient (API) to the US in line with its request.

They said Brazil and Canada are expected to get 50 lakh tablets of hydroxychloroquine in the second consignment. In the first consignment, Brazil will receive 0.53 MT of API.

The sources said Bangladesh will get 20 lakh tablets of hydroxychloroquine, Nepal 10 lakh, Bhutan 2 lakh, Sri Lanka 10 lakh (not in the first consignment), Afghanistan 5 lakh, and Maldives 2 lakh.

They said Germany will also get 50 lakh tablets of HCQ in the second consignment and in the first consignment, it will receiving 1.5 MT API.

The other countries to receive hydroxychloroquine include Seychelles and Dominican Republic.

The sources said India will be sending a total of 14 million tablets and 13.5 MT API.

US President Donald Trump on Wednesday thanked Prime Minister Narendra Modi for allowing the export of HCQ. In a tweet he had also thanked India and the Indian people for the decision on HCQ, saying it will not be forgotten.

Israeli Prime Minister Benjamin Netanyahu also thanked India for sending chloroquine.

.